New biomarker panel could accelerate autism diagnoses

Investigators have identified a group of blood metabolites that could help detect some children with autism spectrum disorder (ASD). These findings are a key step toward developing an ASD biomarker test.

Investigators at the UC Davis MIND Institute and NeuroPointDX, a division of Stemina Biomarker Discovery, have identified a group of blood metabolites that could help detect some children with autism spectrum disorder (ASD). Part of the Children’s Autism Metabolome Project (CAMP), the largest metabolomic ASD study ever attempted, these findings are a key step toward developing an ASD biomarker test. The research was published September 6 in the journal Biological Psychiatry.

Link to full story here